1. |
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol, 2002, 39(12): 1890-1900.
|
2. |
Warden HE, Cohen M, Read RC, et al. Controlled cross circulation for open intracardiac surgery: Physiologic studies and results of creation and closure of ventricular septal defects. J Thorac Surg, 1954, 28(3): 331-341.
|
3. |
Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol, 1997, 30(5): 1374-1383.
|
4. |
Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med, 1993, 329(9): 593-599.
|
5. |
Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet, 2000, 356(9234): 975-981.
|
6. |
Ferraz Cavalcanti PE, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3, 118 patients from 48 studies. J Am Coll Cardiol, 2013, 62(23): 2227-2243.
|
7. |
Weinberg CR, McElhinney DB. Pulmonary valve replacement in tetralogy of Fallot. Circulation, 2014, 130(9): 795-798.
|
8. |
Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg, 2011, 142(2): 351-358.
|
9. |
Stark J, Bull C, Stajevic M, et al. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg, 1998, 115(3): 506-514.
|
10. |
Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation, 2000, 102(19 Suppl 3): III130-135.
|
11. |
胡小松, 杨克明, 李守军, 等. 同种带瓣管道用于右心室流出道重建的中期效果. 中国循环杂志, 2016, 31(4): 385-388.
|
12. |
Oliver JM, Garcia-Hamilton D, Gonzalez AE, et al. Risk factors for prosthetic pulmonary valve failure in patients with congenital heart disease. Am J Cardiol, 2015, 116(8): 1252-1256.
|
13. |
Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart, 2008, 94(2): 211-216.
|
14. |
Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol, 2004, 43(6): 1068-1074.
|
15. |
Zeppenfeld K, Wijnmaalen AP. Clinical aspects and ablation of ventricular arrhythmias in tetralogy of Fallot. Card Electrophysiol Clin, 2017, 9(2): 285-294.
|